NM-2-AI

NM-2-AI
Clinical data
Other namesNM2AI; N-Methyl-2-aminoindane; N-Methyl-2-AI; N-Methyl-AI; AM-80; Methaminoindan; Methoaminoindane
Drug classNorepinephrine releasing agent; Stimulant
ATC code
  • None
Legal status
Legal status
Identifiers
  • N-Methyl-2,3-dihydro-1H-inden-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13N
Molar mass147.221 g·mol−1
3D model (JSmol)
  • CNC2CC1=CC=CC=C1C2
  • InChI=1S/C10H13N/c1-11-10-6-8-4-2-3-5-9(8)7-10/h2-5,10-11H,6-7H2,1H3
  • Key:SXWZQUCTTOBHJT-UHFFFAOYSA-N

NM-2-AI, or NM2AI, also known as N-methyl-2-aminoindane, is a stimulant of the 2-aminoindane family that has been sold online as a designer drug. It is a rigid analogue of methamphetamine. NM-2-AI acts as a selective norepinephrine releasing agent, with affinity for several monoamine receptors.

Pharmacology

Pharmacodynamics

NM-2-AI acts as a highly selective norepinephrine reuptake inhibitor and releasing agent in vitro and does not release serotonin or dopamine even at very high concentrations (100 μM).

NM-2-AI has activity as a norepinephrine reuptake inhibitor (IC50 = 2.4 μM), as well as acting as a TAAR1 receptor agonist (EC50 = 3.3 μM), an α2A adrenergic receptor agonist (Ki = 0.49 μM) and a ligand at the 5-HT1A (Ki = 3.6 μM) and 5-HT2A (Ki = 5.4 μM) receptors.

Pharmacokinetics

Metabolism

In mice, NM-2-AI is metabolized into seven primary urinary metabolites, including 2-AI, two hydroxylated metabolites of 2-AI, and four hydroxylated metabolites of NM-2-AI. One of the hydroxylated 2-AI metabolites, as well as one of the hydroxylated NM-2-AI metabolites, underwent conjugation. NM-2-AI and 2-AI were detected in the hair and blood.

See also